Cargando…
The cardiovascular safety of methylphenidate
What to make of studies that agree to disagree
Autor principal: | Jackson, John W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887615/ https://www.ncbi.nlm.nih.gov/pubmed/27245078 http://dx.doi.org/10.1136/bmj.i2874 |
Ejemplares similares
-
Methylphenidate off-label use and safety
por: Trenque, Thierry, et al.
Publicado: (2014) -
How to Predict the Impact of Methylphenidate on Cardiovascular Risk in Children with Attention Deficit Disorder: Methylphenidate Improves Autonomic Dysfunction in Children with ADHD
por: Buchhorn, Reiner, et al.
Publicado: (2012) -
An inventory of European data sources for the long-term safety evaluation of methylphenidate
por: Murray, Macey L., et al.
Publicado: (2013) -
Methylphenidate-associated myopathy
por: Vargas, Ana Beatriz, et al.
Publicado: (2012) -
Editorial: Attention and Methylphenidate
por: Avital, Avi, et al.
Publicado: (2020)